PUMD / ProUroCare Medical Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2015 ProUroCare Medical Inc.

PUMD / ProUroCare Medical, Inc. / ASHER ENTERPRISES INC - SCHEDULE 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (AMENDMENT NO. 1)* PROUROCARE MEDICAL INC. (Name of issuer) Common Stock, $0.000001 value per share (Title of class of securities) 74373c206 (CUSIP number) March 13, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul

- 15-12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-51774 ProUroCare Medical Inc. (Exact name of registrant as specified in

- S-8 POS

As Filed with the Securities and Exchange Commission on March 12, 2014 Registration No.

- S-8 POS

As Filed with the Securities and Exchange Commission on March 12, 2014 Registration No.

- S-8 POS

As Filed with the Securities and Exchange Commission on March 12, 2014 Registration No.

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 12, 2014 (Date of earliest event reported) ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Commission File Number: 000-51774 Nevada 20–1212923 (State or other jurisdiction of incor

- S-8 POS

As Filed with the Securities and Exchange Commission on March 12, 2014 Registration No.

ProUroCare Medical Inc. To Delist From The OTCQB And Deregister Its Common Stock, Units and Warrants

Exhibit 99.1 FOR IMMEDIATE RELEASE ProUroCare Medical Inc. To Delist From The OTCQB And Deregister Its Common Stock, Units and Warrants MINNEAPOLIS (March 12, 2014) — ProUroCare Medical Inc., a Nevada Corporation (OTCQB: PUMD), developer of the FDA-approved ProUroScan™ prostate imaging system, announced today that it intends to remove its common stock from trading on the OTCQB and to file a Form 1

PUMD / ProUroCare Medical, Inc. / Reiling William - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment #9) ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) William Reiling 4351 Gulf Shore Blvd. North, Unit 6 North, Naples, FL 34103 (Name, Address and Telephone Number of Pers

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 11, 2014 (Date of earliest event reported) ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Commission File Number: 000-51774 Nevada 20–1212923 (State or other jurisdiction of in

PUMD / ProUroCare Medical, Inc. / ASHER ENTERPRISES INC - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 PROUROCARE MEDICAL INC. (Name of issuer) Common Stock, $0.000001 value per share (Title of class of securities) 74373c206 (CUSIP number) November 18, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh

SECURED CONVERTIBLE SUBORDINATED PROMISSORY NOTE

EX-10.1 2 v357984ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE PROVISIONS OF ANY APPLICABLE STATE SECURITIES LAWS. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-51774 ProUro

WARRANT FOR SHARES OF COMMON STOCK OF PROUROCARE MEDICAL INC.

EX-10.2 3 v357984ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 THE WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS (“BLUE SKY LAWS”). NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS W

ProUroCare Announces New Board of Directors Member

FOR IMMEDIATE RELEASE ProUroCare Announces New Board of Directors Member Minneapolis (September 9, 2013 - ProUroCare Medical Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: September 9, 2013 (Date of earliest event reported) ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Commission File Number: 000-51774 Nevada 20–1212923 (State or other jurisdiction of in

Regulation FD Disclosure, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 22, 2013 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Commission (IRS Employer of inc

Shareholders Meeting August 22, 2013 CONFIDENTIAL 1

Shareholders Meeting August 22, 2013 CONFIDENTIAL 1 Safe - Harbor Statement This presentation contains certain "forward - looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995.

CONVERTIBLE SUBORDINATED PROMISSORY NOTE

Exhibit 10.8 THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE PROVISIONS OF ANY APPLICABLE STATE SECURITIES LAWS. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINI

AMENDMENT TO CONSULTING AGREEMENT

EX-10.6 2 v351429ex10-6.htm EXHIBIT 10.6 Exhibit 10.6 AMENDMENT TO CONSULTING AGREEMENT This Amendment to Consulting Agreement (this “Amendment”) is made as of the 30th day of April, 2013, by and between ProUroCare Inc., with its principal place of business in Eden Prairie, MN, (the “Company”) and Stan Myrum with an address of 7348 Xene Lane North, Maple Grove, Minnesota 55311 (“Consultant”). RECI

WARRANT FOR SHARES OF COMMON STOCK OF PROUROCARE MEDICAL INC.

Exhibit 10.9 THE WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”) HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS (“BLUE SKY LAWS”). NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS WARRANT OR THE SECURITIES OR ANY INTEREST

CONVERTIBLE PROMISSORY NOTE

Exhibit 10.10 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR

CONSULTING AGREEMENT

Exhibit 10.7 CONSULTING AGREEMENT This Agreement made by and between ProUroCare Medical Inc., with a place of business at 6440 Flying Cloud Drive, Suite 101, Eden Prairie, Minnesota 55344 (?PUC?), and Alan Shuler with an address at 18815 4 th Avenue North, Minneapolis, MN 55447 (?Consultant?), effective this 13th day of May, 2013; WHEREAS, PUC wishes to avail itself, under the terms of this Agreem

ProUroCare Medical FORM 10-Q (Quarterly Report)

United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-51774 ProUroCare

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement £ Confidential, for Use of the Commission Only (as

- DEFR14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement £ Confidential, for Use of the Commission Only (

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement £ Confidential, for Use of the Commission Only (as

- S-8

As filed with the Securities and Exchange Commission on July 2, 2013 Registration No.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 16, 2013 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Commission (IRS Employer of incorp

PUMD / ProUroCare Medical, Inc. / Reiling William - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. 8 ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) William Reiling 4351 Gulf Shore Blvd. North, Unit 6 North, Naples, FL 34103 (Name, Address and Telephone Number o

Warrant Shares of Common Stock ProUroCare Medical Inc.

EX-4.3 4 v343437ex4-3.htm EXHIBIT 4.3 The Warrant and the securities issuable upon exercise of this Warrant (COLLECTIVELY, the “Securities”) have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or under any state securities or Blue Sky laws (“Blue Sky Laws”). No transfer, sale, assignment, pledge, hypothecation or other disposition of this Warrant or the Se

Warrant Shares of Common Stock ProUroCare Medical Inc.

The Warrant and the securities issuable upon exercise of this Warrant (COLLECTIVELY, the ?Securities?) have not been registered under the Securities Act of 1933, as amended (the ?Securities Act?), or under any state securities or Blue Sky laws (?Blue Sky Laws?).

I promise to pay you, at your address listed above, the

PRO URO CARE INC. CENTRAL BANK 6440 FLYING CLOUD DRIVE 6640 SHADY OAK ROAD Loan Number 926315001 EDEN PRAIRIE, MN 55344 EDEN PRAIRIE, MN 55344 Date 05-11-2013 Maturity Date 01-17-2014 Loan Amount $ 100,000.00 BORROWER'S NAME AND ADDRESS LENDER?S NAME AND ADDRESS Renewal Of 926315002 "I", "me" and "my" means each borrower above, "You" and "your? means the lender, its successors LO/LP INIT JH/DJC to

Warrant Shares of Common Stock ProUroCare Medical Inc.

The Warrant and the securities issuable upon exercise of this Warrant (COLLECTIVELY, the ?Securities?) have not been registered under the Securities Act of 1933, as amended (the ?Securities Act?), or under any state securities or Blue Sky laws (?Blue Sky Laws?).

May 6, 2013

May 6, 2013 [Name] [Address] Dear , This letter is to document our agreement concerning the consideration ProUroCare Medical Inc.

Warrant Shares of Common Stock ProUroCare Medical Inc.

The Warrant and the securities issuable upon exercise of this Warrant (COLLECTIVELY, the ?Securities?) have not been registered under the Securities Act of 1933, as amended (the ?Securities Act?), or under any state securities or Blue Sky laws (?Blue Sky Laws?).

CONVERTIBLE SUBORDINATED PROMISSORY NOTE

THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE PROVISIONS OF ANY APPLICABLE STATE SECURITIES LAWS.

ProUroCare Medical 10-Q (Quarterly Report)

United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-51774 ProUroCare

CONSULTING AGREEMENT

EX-10.7 8 v343437ex10-7.htm EXHIBIT 10.7 CONSULTING AGREEMENT This Agreement made by and between ProUroCare Medical Inc., with a place of business at 6440 Flying Cloud Drive, Suite 101, Eden Prairie, Minnesota 55344 (“PUC”), and Stan Myrum d/b/a LHG Consulting, Inc., with an address at 7348 Xene Lane North, Maple Grove, Minnesota 55311 (“Consultant”), this 8th day of May, 2013, with terms effectiv

May 1, 2013

EX-99.1 2 v343451ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 May 1, 2013 To the Shareholders of ProUroCare Medical Inc.: As the new interim CEO of ProUroCare (the “Company”), I am excited about the Company’s imaging technology and the potential for this technology to address a significant unmet medical need in the field of prostate cancer imaging. This letter is intended to apprise you of certain recent

Financial Statements and Exhibits, Other Events

8-K 1 v3434518k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2013 ProUroCare Medical Inc. (Exact Name of Registrant as Specified in its Charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Commiss

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 17, 2013 ProUroCare Medical Inc.

ProUroCare Announces Changes to Management and Board of Directors

EX-99.1 2 v341961ex99-1.htm EX-99.1 Exhibit 99.1 ProUroCare Announces Changes to Management and Board of Directors MINNEAPOLIS (April 19, 2013) - ProUroCare Medical Inc. (OTCQB: PUMD) is pleased to announce the appointment of Stan Myrum as Interim CEO of the company and as a Director on its Board of Directors. Stan has over 30 years of medical device experience with Medtronic where he provided exe

ProUroCare Medical 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-51774 ProUroCare Medical Inc. (Exact name of r

- NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2012 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report o

PROMISSORY NOTE

PROMISSORY NOTE Principal $500,000.00 Loan Date 02-15-2013 Maturity 02-15-2014 Loan No 4060026 Call/Coll 610 Account Officer KRH Initials References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing"' •• " has been omitted due to text length limitations. Borrower: PROUROCARE MEDICAL. INC Lender

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2013 ProUroCare Medical Inc.

PUMD / ProUroCare Medical, Inc. / Hanson Michael John - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. 2 ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) Michael J. Hanson 7624 Mississippi Lane Brooklyn Park, MN 55444 (Name, Address and Telephone Number of Person Aut

PUMD / ProUroCare Medical, Inc. / Reiling William - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. 7 ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) William Reiling 4351 Gulf Shore Blvd. North, Unit 6 North, Naples, FL 34103 (Name, Address and Telephone Number o

PUMD / ProUroCare Medical, Inc. / Petersen Jack Barry - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. 2 ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) Jack B Petersen 415 Knollwood Rd, Ridgewood, NJ 07450 (Name, Address and Telephone Number of Person Authorized to

PUMD / ProUroCare Medical, Inc. / Seaside 88, Lp - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ProUroCare Medical Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 74373C206 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

I promise to pay you, at your address listed above, the

EX-10.1 2 v332917ex10-1.htm EXHIBIT 10.1 PRO URO CARE INC. CENTRAL BANK 6440 FLYING CLOUD DRIVE 6640 SHADY OAK ROAD Loan Number 926315001 EDEN PRAIRIE, MN 55344 EDEN PRAIRIE, MN 55344 Date 01-17-2013 Maturity Date 01-17-2014 Loan Amount $ 100,025.00 BORROWER'S NAME AND ADDRESS LENDER’S NAME AND ADDRESS Renewal Of 926315001 "I", "me" and "my" means each borrower above, "You" and "your” means the le

MODIFICATION/AMENDMENT ProUroCare Medical, Inc Loan #4060026

EX-10.2 3 v332917ex10-2.htm EXHIBIT 10.2 CROWN BANK 6600 FRANCE AVENUE SOUTH, SUITE 125 EDINA. MINNESOTA 55435 MODIFICATION/AMENDMENT ProUroCare Medical, Inc Loan #4060026 January 23, 2013 The above referenced loan originally dated January 11, 2006 in the original amount of $1,200,000.00, which may have been amended and restated from time to time is further modified and/or amended as follows: The

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2013 ProUroCare Medical Inc.

ProUroCare Appoints Life Science Veteran as Interim Chief Operating Officer

EX-99.1 2 v330253ex99-1.htm EXHIBIT 99.1 ProUroCare Appoints Life Science Veteran as Interim Chief Operating Officer MINNEAPOLIS (December 13, 2012) – ProUroCare Medical Inc. (OCTQB: PUMD), developer of the FDA-approved ProUroScan™ prostate imaging system, announced that life sciences veteran Doris Engibous has entered into a contract to act as its interim Chief Operating Officer. Ms. Engibous’ pr

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) December 12, 2012 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Commission (IRS Employer of i

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

8-K 1 v3295848k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) November 29, 2012 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (

Dr. Michael Chambers Elected Chairman of ProUroCare Board of Directors

EX-99.1 3 v329584ex99-1.htm EXHIBIT 99.1 Dr. Michael Chambers Elected Chairman of ProUroCare Board of Directors MINNEAPOLIS (November 30, 2012) – ProUroCare Medical Inc. (OCTQB: PUMD), developer of the FDA-approved ProUroScan™ prostate imaging system, announced that current director Dr. Michael Chambers, JD, Ph.D., has been named Chairman of its Board of Directors. Dr. Chambers is an experienced b

MODIFICATION/AMENDMENT ProUroCare Medical, Inc Loan #4060026

EX-10.1 2 v329584ex10-1.htm EXHIBIT 10.1 CROWN BANK 6600 FRANCE AVENUE SOUTH, SUITE 125 EDINA. MINNESOTA 55435 MODIFICATION/AMENDMENT ProUroCare Medical, Inc Loan #4060026 November 28, 2012 The above referenced loan originally dated January 11, 2006 in the original amount of $1,200,000.00, which may have been amended and restated from time to time is further modified and/or amended as follows: The

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2012 ProUroCare Medical Inc.

Dr. David M. Barrett Joins ProUroCare Board of Directors

Dr. David M. Barrett Joins ProUroCare Board of Directors MINNEAPOLIS (November 5, 2012) – ProUroCare Medical Inc. (OCTQB: PUMD), a provider of proprietary medical imaging products, today announced that Dr. David M. Barrett, MD, was elected to ProUroCare’s Board of Directors at their quarterly board meeting. He is the former President and CEO of the Lahey Clinic in Burlington, Massachusetts, which

Promissory Note

Promissory Note EFFECTIVE DATE AND PARTIES. This Promissory Note (“Note”) is made effective as of October 29, 2012. The parties and their addresses are: LENDER (“you” and “your”): Jeanne Rudelius 1850 Major Dr. Golden Valley, MN 55422 BORROWER (“we,” “us,” and “our”): ProUroCare Medical Inc. a Nevada Corporation 6440 Flying Cloud Dr., STE 101 Eden Prairie, MN 55344 PROMISE TO PAY. For value receiv

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2012 ProUroCare Medical Inc.

Promissory Note

Promissory Note EFFECTIVE DATE AND PARTIES. This Promissory Note (“Note”) is made effective as of September 26, 2012. The parties and their addresses are: LENDER (“you” and “your”): Jeanne Rudelius 1850 Major Dr. Golden Valley, MN 55422 BORROWER (“we,” “us,” and “our”): ProUroCare Medical Inc. a Nevada Corporation 6440 Flying Cloud Dr., STE 101 Eden Prairie, MN 55344 PROMISE TO PAY. For value rece

Amendment No. 1 to Promissory Note 11-1 Dated February 8, 2011

Amendment No. 1 to Promissory Note 11-1 Dated February 8, 2011 This Amendment No. 1 to Promissory Note 11-1 dated February 8, 2011 issued by ProUroCare Medical Inc. in favor of Jack Petersen (the “Note”) is made to amend the Maturity Date and the Conversion Price of the Note. The following defined terms of the Note are hereby changed as defined below: “Maturity Date” The Maturity Date shall be Aug

Amendment No. 1 to Promissory Note 11-2 Dated February 10, 2011

Amendment No. 1 to Promissory Note 11-2 Dated February 10, 2011 This Amendment No. 1 to Promissory Note 11-2 dated February 10, 2011 issued by ProUroCare Medical Inc. in favor of Maslon, Edelman, Borman & Brand, LLP (the “Note”) is made to amend the Maturity Date and the Conversion Price of the Note. The following defined terms of the Note are hereby changed as defined below: “Maturity Date” The M

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 26, 2012 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Commission (IRS Employer of

Shareholder Update September 2012

Shareholder Update September 2012 Safe - Harbor Statement This presentation contains certain "forward - looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Regulation FD Disclosure, Financial Statements and Exhibits - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 18, 2012 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Commission (IRS Employer of

PROUROCARE MEDICAL INC. 2012 STOCK PLAN

Exhibit 10.1 PROUROCARE MEDICAL INC. 2012 STOCK PLAN 1. Purpose. The purpose of the 2012 Stock Plan (the “Plan”) of ProUroCare Medical Inc. (the “Company”), a Nevada corporation, is to increase shareholder value and to advance the interests of the Company by furnishing a variety of economic incentives (variously referred to hereinafter as the “Incentives”) designed to attract, retain and motivate

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 v3225938k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2012 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Com

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 6, 2012 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Commission (IRS Employer of inco

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement £ Confidential, for Use of the Commission Only (as

Unregistered Sales of Equity Securities - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2012 ProUroCare Medical Inc.

- FORM DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement £ Confidential, for Use of the Commission Only (as

FOURTH AMENDMENT TO DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

FOURTH AMENDMENT TO DEVELOPMENT AND COMMERCIALIZATION AGREEMENT THIS FOURTH AMENDMENT TO DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (this “Fourth Amendment”) is made as of the 24th day of May, 2012, by and between Artann Laboratories, Inc.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) May 24, 2012 ProUroCare Medical Inc. (Exact name of registrant as specified in its charter) Nevada 000-51774 20-1212923 (State or other jurisdiction (Commission (IRS Employer of incorp

Unregistered Sales of Equity Securities - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2012 ProUroCare Medical Inc.

ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System Approved to make real-time, color images of men’s prostate glands, ProUroCare will next pilot the clinical technology in select medical centers

Exhibit 99.1 ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System Approved to make real-time, color images of men’s prostate glands, ProUroCare will next pilot the clinical technology in select medical centers MINNEAPOLIS (May 1, 2012) – ProUroCare Medical Inc. (OCTBB: PUMD), provider of proprietary medical imaging products, announced today it has received clearance f

Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2012 ProUroCare Medical Inc.

The following table sets forth all acquisitions of common stock of the Issuer by the Reporting Persons during the sixty days preceding the filing of this Amendment No. 4 to Schedule 13D.

CUSIP NO: 74373C 10 7 Page 9 of 9 EXHIBIT 99.1 The following table sets forth all acquisitions of common stock of the Issuer by the Reporting Persons during the sixty days preceding the filing of this Amendment No. 4 to Schedule 13D. Reporting Person Date Number of Shares Conversion/ Purchase Price Convertible Debt Shares Transactions Mr. Davis 2/8/12 77,586 - - Issued to reporting person as compe

PUMD / ProUroCare Medical, Inc. / DAVIS JAMES L - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) James L. Davis 6446 Flying Cloud Drive Eden Prairie, MN 55344 (Name, Address and Telephone Number of Person Autho

March 30, 2012

March 30, 2012 Dear , This letter is to amend our October 11, 2011 agreement concerning the consideration ProUroCare Medical Inc.

FORM OF CONVERTIBLE SUBORDINATED PROMISSORY NOTE

Exhibit 99.1 THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE PROVISIONS OF ANY APPLICABLE STATE SECURITIES LAWS. THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINI

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sales of Equity Securities, Unregistered Sales of Equity Securities -

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2012 ProUroCare Medical Inc.

- NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): x Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2011 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report o

PUMD / ProUroCare Medical, Inc. / Seaside 88, Lp - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ProUroCare Medical Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 74373C206 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

PUMD / ProUroCare Medical, Inc. / Reiling William Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. 6 ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) William Reiling 4351 Gulf Shore Blvd. North, Unit 6 North, Naples, FL 34103 (Name, Address and Telephone Number o

PUMD / ProUroCare Medical, Inc. / Petersen Jack Barry Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. 1 ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) Jack B Petersen 415 Knollwood Rd, Ridgewood, NJ 07450 (Name, Address and Telephone Number of Person Authorized to

PUMD / ProUroCare Medical, Inc. / DAVIS JAMES L Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) James L. Davis 6446 Flying Cloud Drive Eden Prairie, MN 55344 (Name, Address and Telephone Number of Person Autho

The following table sets forth all acquisitions of common stock of the Issuer by the Reporting Persons during the sixty days preceding the filing of this Amendment No. 3 to Schedule 13D.

EXHIBIT 99.1 The following table sets forth all acquisitions of common stock of the Issuer by the Reporting Persons during the sixty days preceding the filing of this Amendment No. 3 to Schedule 13D. None.

PUMD / ProUroCare Medical, Inc. / Hanson Michael John Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. 6 ProUroCare Medical Inc. (Name of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securities) 74373C 10 7 (CUSIP Number) Michael J. Hanson 7624 Mississippi Lane Brooklyn Park, MN 55444 (Name, Address and Telephone Number of Person Aut

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2012 ProUroCare Medical Inc.